GlaxoSmithKline would consider buying Pfizer’s consumer health business – but only if the price is right, according to the company's chief executive. Emma Walmsley has also been busy shaking ...
GlaxoSmithKline has found a replacement for head of vaccines R&D Emmanuel Hanon, who left the company for a US biotech earlier this year, hiring Phil Dormitzer from ...
The FDA has required the manufacturers of the RSV Vaccines Abrysvo and Arexvy to add a new warning to their labels about the ...
The FDA has mandated updated safety labeling for two respiratory syncytial virus vaccines, Pfizer's Abrysvo and GlaxoSmithKline's Arexvy, following the identification of an increased risk of ...
The Post has sought comment from Pfizer. Zantac was brought to market in 1983 by Glaxo Holdings, a company that is now part ...
Painkiller brands Panadol and Anadin will be bought under one roof under a giant deal between drug firms GlaxoSmithKline and Pfizer. The firms are combining their consumer healthcare businesses ...
Moderna stock was on track to see a weekly gain of 10% as of Wednesday following the first reported bird flu death in the US.
A 13-year-old girl in Canada became so sick with H5N1, or bird flu, in late 2024 that she had to be put on a ventilator.
GlaxoSmithKline will combine its consumer health business with Pfizer - split at 68% to 32% in equity holdings respectively - and its shares rose as much as 7.4% on the announcement. GSK is ...
Berenberg Bank analyst Kerry Holford maintained a Hold rating on FRESNILLO (FNLPF – Research Report) yesterday and set a price target of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback